CochLear Debt Issuance/Retirement Net - Total 2023-2023 | CHEOY
CochLear annual/quarterly debt issuance/retirement net - total history and growth rate from 2023 to 2023. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
- CochLear debt issuance/retirement net - total for the quarter ending December 31, 2023 was $-0.028B, a INF% decline year-over-year.
- CochLear debt issuance/retirement net - total for the twelve months ending December 31, 2023 was $-0.028B, a INF% decline year-over-year.
- CochLear annual debt issuance/retirement net - total for 2023 was $-0.049B, a 163.51% increase from 2022.
- CochLear annual debt issuance/retirement net - total for 2022 was $-0.019B, a INF% decline from 2021.
- CochLear annual debt issuance/retirement net - total for 2021 was $0B, a NAN% decline from 2020.
| CochLear Annual Debt Issuance/Retirement Net - Total (Millions of US $) |
|
|---|---|
| 2023 | $-49 |
| 2022 | $-19 |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.061B | $1.317B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.882B | 15.80 |
| Cencora (COR) | United States | $44.079B | 17.18 |
| ICON (ICLR) | Ireland | $26.293B | 24.82 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| Avantor (AVTR) | United States | $16.934B | 24.93 |
| Revvity (RVTY) | United States | $13.822B | 24.25 |
| Viatris (VTRS) | United States | $13.181B | 3.94 |
| Natera (NTRA) | United States | $13.055B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.308B | 40.49 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.722B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.490B | 22.00 |
| Solventum (SOLV) | United States | $10.713B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.542B | 0.00 |
| HealthEquity (HQY) | United States | $6.909B | 50.90 |
| Organon (OGN) | United States | $5.599B | 5.31 |
| Doximity (DOCS) | United States | $5.403B | 37.61 |
| Bausch + Lomb (BLCO) | Canada | $5.101B | 20.44 |
| PACS (PACS) | United States | $4.287B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.237B | 29.62 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| Life Times (LTH) | United States | $3.042B | 31.88 |
| GoodRx Holdings (GDRX) | United States | $2.675B | 101.86 |
| Progyny (PGNY) | United States | $2.666B | 45.90 |
| NovoCure (NVCR) | Jersey | $2.588B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.265B | 8.98 |
| Agilon Health (AGL) | United States | $2.204B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.086B | 0.00 |
| Premier (PINC) | United States | $2.048B | 8.76 |
| BrightSpring Health Services (BTSG) | United States | $1.962B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.486B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.380B | 0.00 |
| CareDx (CDNA) | United States | $0.814B | 0.00 |
| Embecta (EMBC) | United States | $0.803B | 5.46 |
| Pediatrix Medical (MD) | United States | $0.628B | 6.66 |
| Auna S.A (AUNA) | Luxembourg | $0.623B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.612B | 16.01 |
| InnovAge Holding (INNV) | United States | $0.586B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.568B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.541B | 0.00 |
| Enhabit (EHAB) | United States | $0.449B | 44.75 |
| Sonida Senior Living (SNDA) | United States | $0.433B | 0.00 |
| ModivCare (MODV) | United States | $0.392B | 7.34 |
| MultiPlan (MPLN) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.334B | 0.00 |
| Beauty Health (SKIN) | United States | $0.320B | 0.00 |
| DocGo (DCGO) | United States | $0.309B | 16.89 |
| Sharecare (SHCR) | United States | $0.303B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.268B | 0.00 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| So-Young (SY) | China | $0.114B | 38.17 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 6.56 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Oncology Institute (TOI) | United States | $0.045B | 0.00 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.031B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.016B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| DermTech (DMTK) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| OpGen (OPGN) | United States | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |